Table 1.
Summary of peptides identified in Alzheimer’s disease and cancer samples by the JUMPg program
Database | Dataset 1: Alzheimer’s disease brain
|
Dataset 2: Multiple myeloma
|
||||
---|---|---|---|---|---|---|
Search space* | PSMs | Peptides | Search space* | PSMs | Peptides | |
1st stage (fully tryptic) | ||||||
UniProt | 5,086,244 | 556,551 | 87,806 | 5,086,244 | 723,521 | 129,861 |
Mutation | 56,085 | 1,401 | 288 | 63,708 | 1,931 | 584 |
Splice junction | 152,662 | 155 | 51 | 742,585 | 316 | 163 |
2nd stage (partially tryptic)# | ||||||
UniProt | 43,998,844 | 26,030 | 6,621 | 47,273,429 | 182,737 | 67,251 |
mutation | 42,761 | 33 | 10 | 98,348 | 237 | 114 |
junction | 14,317 | 0 | 0 | 51,899 | 14 | 3 |
3rd stage (fully tryptic) | ||||||
RNAseq 6FT | 3,633,953 | 569 | 147 | 4,523,368 | 467 | 127 |
| ||||||
Total | 584,739 | 94,923 | 909,223 | 198,103 |
The search space is indicated by the number of unique theoretical peptides in a particular database.
Only proteins/events identified in the 1st stage are considered in partially tryptic database search.